Claraphi Advisory Network’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-708
| Closed | -$292K | – | 299 |
|
|
2021
Q3 | $292K | Buy |
+708
| New | +$292K | 0.1% | 220 |
|
|
2020
Q3 | – | Sell |
-1,163
| Closed | -$203K | – | 260 |
|
|
2020
Q2 | $203K | Buy |
1,163
+9
| +0.8% | +$1.57K | 0.09% | 239 |
|
|
2020
Q1 | $146K | Buy |
+1,154
| New | +$146K | 0.07% | 254 |
|
|
2019
Q2 | – | Sell |
-1,432
| Closed | -$208K | – | 244 |
|
|
2019
Q1 | $208K | Buy |
+1,432
| New | +$208K | 0.13% | 205 |
|
|
2018
Q4 | – | Sell |
-1,943
| Closed | -$262K | – | 219 |
|
|
2018
Q3 | $262K | Buy |
1,943
+115
| +6% | +$15.5K | 0.15% | 194 |
|
|
2018
Q2 | $206K | Buy |
+1,828
| New | +$206K | 0.13% | 232 |
|